Business
Proposed Placing & Open Offer, Launch of ABB
Proposed Placing & Open Offer, Launch of ABB.
About this update from Creo Medical Group Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 5145I\n Creo Medical Group PLC\n 12 August 2021\n \n \n \n \n \n \n \n THIS ANNOUNCEMENT (INCLUDING THE APPENDIX) AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, NEW ZEALAND OR JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. PLEASE SEE THE IMPORTANT NOTICES AT THE END OF THIS ANNOUNCEMENT.\n \n \n \n \n \n THIS ANNOUNCEMENT WAS DEEMED BY THE COMPANY TO CONTAIN INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATIONS (EU) NO. 596/2014 AS THEY FORM PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. WITH THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.\n \n \n \n \n \n 12 August 2021\n \n \n \n \n \n Creo Medical Group plc\n \n \n (\"Creo\" or the \"Company\")\n \n \n \n \n \n Proposed Placing to raise a minimum of £30 million\n \n \n Launch of Accelerated Book Build\n \n \n Proposed Open Offer to raise up to approximately £5 million\n \n \n \n \n \n Creo Medical Group plc (AIM: CREO), a medical device company focused on the emerging field of surgical endoscopy is pleased to announce a proposed Placing by way of an accelerated bookbuild to raise a minimum of £30 million (before expenses) via a conditional placing of new Ordinary Shares at the issue price of 182.5p per share to new and existing institutional investors, to support further growth of the Group and development of its business. The accelerated book build process is expected to close on 13 August 2021, following which the final quantum of the Placing proceeds will be announced.\n \n \n \n \n \n Furthermore, the Company is proposing to raise up to approximately £5 million by way of an Open Offer which will be available to all Qualifying Shareholders on the Record Date.\n \n \n \n \n \n Transaction Highlights \n \n \n \n \n \n •\n \n \n \n \n Conditional Placing to raise a minimum of £30 million at the Issue Price\n \n \n \n \n \n \n •\n \n \n \n \n Open Offer to raise gross proceeds of up to an additional £5 million at the Issue price\n \n \n \n \n \n \n •\n \n \n ...